Investing.com - Financial Markets Worldwide

Bio-Gene Technology Ltd (BGT)

Sydney
Currency in AUD
0.035
0.000(0.00%)
Delayed Data·
BGT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BGT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.0350.037
52 wk Range
0.0160.071
Key Statistics
Edit
Bid/Ask
0.034 / 0.035
Prev. Close
0.035
Open
0.037
Day's Range
0.035-0.037
52 wk Range
0.016-0.071
Volume
45.67K
Average Volume (3m)
746.04K
1-Year Change
-31.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BGT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Quickly burning through cash
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Bio-Gene Technology Ltd Company Profile

Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; and Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University for experiments demonstrating the value of pre-conditioning biomass prior to distillation; Cesar for assessing the insecticidal activity of its molecules against a range of insect species; Advanced Molecular Technologies; CSIRO for a chemistry development process; the Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University for chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications, as well as insect management in crop protection. The company was incorporated in 1995 and is based in Melbourne, Australia.

Industry
Chemicals
Sector
Basic Materials
0
Market
Australia

Compare BGT to Peers and Sector

Metrics to compare
BGT
Peers
Sector
Relationship
P/E Ratio
−4.1x−6.0x0.0x
PEG Ratio
−0.70−0.060.00
Price/Book
6.6x1.7x1.6x
Price / LTM Sales
-4.6x1.4x
Upside (Analyst Target)
-108.4%17.7%
Fair Value Upside
Unlock−4.3%−1.8%Unlock

Earnings

Latest Release
Aug 25, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

BGT Income Statement

People Also Watch

Electro Optic Systems Holdings
8.78
EOS
+0.34%
James Hardie Industries
31.21
JHX
+4.17%
Domino'S Pizza Enterprises
13.51
DMP
+0.07%
Origin Energy
12.400
ORG
+1.06%
Imdex
3.535
IMD
+0.71%

FAQ

What Stock Exchange Does Bio-Gene Tech Trade On?

Bio-Gene Tech is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Bio-Gene Tech?

The stock symbol for Bio-Gene Tech is "BGT."

What Is the Bio-Gene Tech Market Cap?

As of today, Bio-Gene Tech market cap is 10.68M.

What Is Bio-Gene Tech's Earnings Per Share (TTM)?

The Bio-Gene Tech EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is BGT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bio-Gene Tech Stock Split?

Bio-Gene Tech has split 0 times.

How Many Employees Does Bio-Gene Tech Have?

Bio-Gene Tech has 0 employees.

What is the current trading status of Bio-Gene Tech (BGT)?

As of 05 Oct 2025, Bio-Gene Tech (BGT) is trading at a price of 0.035, with a previous close of 0.04. The stock has fluctuated within a day range of 0.035 to 0.037, while its 52-week range spans from 0.016 to 0.071.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.